---

---

publishing date : 2022 - 10 - 31    tags : Earnings   

save search

---

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
XGN | $1.42 -0.62% -0.63% 6.6K |

Health Services

| -46.48% | O: 0.78% H: 9.3% C: -5.04%
financial results

---

Apellis Pharmaceuticals to Host Conference Call on Nov 7, 2022 to Discuss Third Quarter 2022 Financial Results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
APLS G | $47.53 0.04% 0.04% 1.2M |

Health Technology

| -21.57% | O: -0.71% H: 1.79% C: 0.53%
pharmaceuticals conference financial results

---

Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 19.45% | O: -0.74% H: 2.09% C: 0.48%
KNSA | $16.93 0.3% 0.3% 380K |

Health Technology

| 44.28% | O: 0.26% H: 1.53% C: -2.81%
pharmaceuticals report financial results

---

Stryker reports third quarter 2022 operating results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
SYK | $325.43 -0.62% 0.0% 1.8M |

Health Technology

| 41.97% | O: -0.61% H: 0.86% C: 0.62%
results

---

Axonics® Reports Third Quarter 2022 Financial Results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
AXNX | $66.96 -0.13% -0.13% 590K |

Health Technology

| -6.88% | O: -1.04% H: 5.61% C: 2.8%
axonics financial results

---

Nanox to Report Third Quarter 2022 Financial Results on November 10, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
NNOX | $8.62 -4.96% -5.22% 1M |

Health Technology

| -35.87% | O: -0.6% H: 7.88% C: 6.53%
report financial results

---

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
ACHV | $4.51 -1.31% -1.33% 35K |

Health Technology

| 100.44% | O: 1.33% H: 3.2% C: -3.07%
sciences conference life financial results

---

Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
BVS S | $4.48 -1.54% -1.56% 130K |

| -43.29% | O: -0.38% H: 5.34% C: 3.43%
report year financial results

---

TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
TCON | $1.97 -6.64% -7.11% 240K |

Health Technology

| 21.74% | O: -0.62% H: 1.87% C: -1.25%
report financial update results

---

Albireo to Report Q3 2022 Financial Results on November 8, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
ALBO | $44.15 -0.23% 0.39% 1.2M |

Health Technology

| 108.73% | O: 0.24% H: 0.0% C: 0.0%
report financial results

---

PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2022 Financial Results
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
PDSB | $2.64 -8.97% -9.85% 880K |

Health Technology

| -50.74% | O: 0.56% H: 0.18% C: -3.14%
conference financial

---

Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
CNCE | $8.37 0.36% 0 |

Health Technology

| 38.97% | O: -0.25% H: 0.0% C: 0.0%
pharmaceuticals report results

---

Compugen to Release Third Quarter 2022 Results on Monday, November 14, 2022
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K |

Health Technology

| 161.71% | O: -1.17% H: 10.26% C: 10.06%
results

---

Lantern Pharma to Report Third Quarter 2022 Operating & Financial Results on November 7, 2022 at 4:30 p.m. ET
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K |

Health Technology

| 24.19% | O: -1.16% H: 3.76% C: -1.41%
pharma report financial results

---

Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| 7.71% | O: -0.7% H: 0.0% C: 0.0%

---

Theravance Biopharma to Report Third Quarter 2022 Financial Results on November 7, 2022
Published: 2022-10-31 (Crawled : 11:00) - biospace.com/
TBPH | $9.35 1.63% 1.6% 430K |

Health Technology

| -6.51% | O: 0.7% H: 0.0% C: -0.89%
biopharma report financial results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

---

Your saved searches

---